Ernexa Therapeutics Inc. Other Current Liabilities
Ernexa Therapeutics Inc. (ERNA) had Other Current Liabilities of $124.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Current $124.00K.
- 2026-03-31: Other Liabilities, Current $218.00K.
- 2025-12-31: Other Liabilities, Current $83.00K.
- 2025-09-30: Other Liabilities, Current $63.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $124.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $218.00K 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $83.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $63.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $125.00K 10-Q · filed 2025-08-13 | |
| 2024-09-30 | $113.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $225.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $768.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.21M 10-Q · filed 2024-05-14 | |
| 2023-03-31 | $8.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $363.00K 10-Q · filed 2023-05-11 | |
| 2022-09-30 | $2.65M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.43M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $45.00K 10-Q · filed 2022-07-01 | |
| 2021-12-31 | $247.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $617.66K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $985.23K 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $0.00 10-K/A · filed 2022-07-01 | $139.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $154.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $233.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $286.00K 10-Q · filed 2020-05-20 | |
| 2019-12-31 | $419.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $171.00K 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $231.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $198.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $337.00K 10-K · filed 2020-03-19 | $233.00K 10-K · filed 2019-03-22 |
| 2018-09-30 | $96.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $98.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $146.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $192.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $106.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $165.00K 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $347.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $291.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $215.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $284.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $534.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $639.00K 10-K · filed 2017-03-09 | |
| 2015-09-30 | $313.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $147.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $387.00K 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $481.00K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $120.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $153.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $187.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $237.00K 10-K · filed 2015-03-27 | |
| 2013-09-30 | $345.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $340.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $346.00K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $367.00K 10-K · filed 2014-03-31 | $408.00K 10-K · filed 2013-03-29 |
| 2012-09-30 | $285.00K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $110.00K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $184.00K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $192.00K 10-K · filed 2013-03-29 | |
| 2011-09-30 | $47.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $19.00K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $74.00K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |